|4Dec 11, 5:24 PM ET

EMIGH JAMES F 4

4 · ACURA PHARMACEUTICALS, INC · Filed Dec 11, 2017

Insider Transaction Report

Form 4
Period: 2017-12-11
EMIGH JAMES F
VP Marketing & Administration
Transactions
  • Award

    Restricted Stock Units

    2017-12-11+14,00014,000 total
    Common Stock (14,000 underlying)
Footnotes (4)
  • [F1]Awarded under the Acura Pharmaceuticals Inc. 2017 Restricted Stock Unit Award Plan (the "Plan").
  • [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
  • [F3]100% of Restricted Stock Units vest on December 11, 2018 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2020, 2021, and 2022 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
  • [F4]N/A

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION